Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM
Mar 2, 2026 04:05PM
Feb 17, 2026 07:00AM
Feb 4, 2026 06:48AM
Feb 2, 2026 07:02AM
Feb 2, 2026 07:00AM Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM
Nov 10, 2025 04:05PM
Oct 6, 2025 07:00AM
Oct 6, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM Harrow to Acquire Melt Pharmaceuticals
Sep 25, 2025 04:06PM
Sep 25, 2025 04:05PM
Sep 23, 2025 06:45AM
Sep 15, 2025 07:00AM
Aug 11, 2025 04:01PM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
Jun 18, 2025 07:00AM
Jun 9, 2025 07:03AM
Jun 9, 2025 07:00AM
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM
Mar 27, 2025 04:01PM
Mar 24, 2025 07:05AM Harrow Health (HROW) Announces Transitional Pass-Through Reimbursement Status for TRIESENCE 40 mg/mL
Mar 24, 2025 07:00AM
Mar 17, 2025 04:01PM
Mar 17, 2025 07:00AM
Mar 11, 2025 07:00AM
Jan 27, 2025 07:30AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM Harrow Appoints Amir H. Shojaei as Chief Scientific Officer
Nov 21, 2024 07:02AM
Nov 21, 2024 07:00AM
Nov 13, 2024 04:34PM
Nov 13, 2024 07:00AM
Nov 12, 2024 07:07AM
Nov 12, 2024 07:00AM
Nov 7, 2024 07:00AM Harrow Partners with Asembia to Enhance Provider and Patient Experience Through Nationwide Digital Services and Hub Support for Harrow’s Branded Eyecare Products
Oct 3, 2024 07:02AM
Oct 3, 2024 07:00AM
Aug 7, 2024 04:01PM
Jul 12, 2024 07:00AM
Jul 9, 2024 07:02AM
Jul 9, 2024 07:00AM
Jun 20, 2024 07:04AM Harrow Health (HROW) Provides TRIESENCE Relaunch Update
Jun 20, 2024 07:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All